Front Row Advisors LLC Ark Genomic Revolution ETF (De Transaction History
Front Row Advisors LLC
- $276 Million
- Q2 2025
A detailed history of Front Row Advisors LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Front Row Advisors LLC holds 5 shares of ARKG stock, worth $161. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5
Previous 5
-0.0%
Holding current value
$161
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARKG
# of Institutions
283Shares Held
19MCall Options Held
3.93MPut Options Held
4.4M-
Jpmorgan Chase & CO New York, NY3.43MShares$111 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY3.18MShares$103 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.13MShares$68.6 Million0.0% of portfolio
-
Ubs Group Ag1.35MShares$43.6 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA1.09MShares$35.1 Million0.01% of portfolio